Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174783 · ClinicalTrials.gov registry record · NA
Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02174783 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 25 participants.
The verdict
NCT02174783, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Many metabolic complications can develop after liver transplant including: diabetes, high blood pressure, obesity, heart attacks and stroke. The goal of this study is to look at the safety and effect of 2 well known and established diet regimens on the people who had a prior liver transplant and investigate whether it helps with the control of these comorbidities.
Interventions
- OTHER Control group
- OTHER Mediterranean diet
- OTHER Protein-Sparing Modified Fast (PSMF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02174783
The ClinicalTrials.gov registry entry for NCT02174783 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control group is the first listed.
NCT02174783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02174783 about?
NCT02174783 is a clinical study titled "Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients". Many metabolic complications can develop after liver transplant including: diabetes, high blood pressure, obesity, heart attacks and stroke. The goal of this study is to look at the safety and effect of 2 well known and established diet regimens on the people who had a prior liver transplant and inv...
What is the current status of trial NCT02174783?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2014-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02174783?
The interventions under investigation include: Control group (OTHER), Mediterranean diet (OTHER), Protein-Sparing Modified Fast (PSMF) (OTHER).
Who is sponsoring clinical trial NCT02174783?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.